Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Integrates MetaCore, MetaDrug with Open Source Cytoscape Platform

NEW YORK (GenomeWeb News) – GeneGo said today it has integrated two of its data analysis software offerings with Cytoscape, an open source pathway-visualization package developed by the Institute for Systems Biology and other academic partners.
 
GeneGo said it is integrating its MetaCore 4.5 software, used in target selection and validation for toxicology, and MetaDrug 4.5, which is used to study the toxicity and biological effects of novel small-molecule compounds.
 
The company said plug-ins are available for network and molecular profiling analyses, new layouts, additional file format support and connection.
 
GeneGo first mentioned its plans to integrate its software with Cytoscape in July, when ISB licensed its MetaCore and 1-2-3 Workflow software.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.